Profile
SILO NVO REGN VRTX SGEN ALNY
Company Name Silo Pharma, Inc. Novo Nordisk A/S Regeneron Pharmaceuticals, Inc. Vertex Pharmaceuticals Incorporated Seagen Inc. Alnylam Pharmaceuticals, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $5.25M $597.35B $128.44B $127.99B $43.15B $33.72B
Employees 0.00K 69.26K 13.93K 5.40K 3.26K 2.10K
CEO Mr. Eric Weisblum Mr. Lars Fruergaard Jorgensen Dr. Leonard S. Schleifer M.D., Ph.D. Dr. Reshma Kewalramani FASN, M.D. Mr. David R. Epstein B.Sc., M.B.A. Dr. Yvonne L. Greenstreet M.B.A., MBChB
Ratings
SILO NVO REGN VRTX SGEN ALNY
Quant Rating Score 2 3 4 2 3 2
Quant Rating Sell Neutral Buy Sell Neutral Sell
Trading
SILO NVO REGN VRTX SGEN ALNY
Last Close $1.17 $139.16 $1184.69 $495.89 $228.74 $262.69
High 52 $3.47 $199.54 $1201.76 $505.78 $228.9 $287.01
Low 52 $0.86 $87.78 $775.18 $343 $204.43 $143.31
Price vs. 52 Week High -66.28 % -30.26 % -1.42 % -1.96 % -0.07 % -8.47 %
Price vs. 52 Week Low 36.05 % 58.53 % 52.83 % 44.57 % 11.89 % 83.3 %
Total Return
SILO NVO REGN VRTX SGEN ALNY
1 Month Return -41.21 % 5.06 % 8.37 % -1.96 % 0 % -2.2 %
3 Month Return -43.75 % 2.87 % 20.87 % 8.91 % 0 % 76.98 %
6 Month Return -27.33 % 12.02 % 20.54 % 14.59 % 0 % 72.13 %
9 Month Return -19.31 % 38.61 % 45.39 % 41.21 % 7.53 % 53.25 %
YTD Return -18.75 % 34.52 % 34.89 % 21.87 % 0 % 37.24 %
1 Year Return -42.08 % -26.49 % 42.45 % 41.24 % 10.02 % 30.58 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
SILO NVO REGN VRTX SGEN ALNY
Dividend Yield Percentage (TTM) - 0.15 % - - - -
Dividend Paid and Capex Coverage Ration (TTM) - 1.26 % 4.72 % -1.96 % -3.35 % 6.97 %
Dividend Per Share (TTM) - 0.21 % - - - -
Payout Ratio (TTM) - 46.71 % - - - -
Growth
SILO NVO REGN VRTX SGEN ALNY
Asset Growth -33.47 % 30.35 % 13.23 % 25.23 % -1.21 % 7.99 %
Gross Profit Growth -1315.38 % 32.32 % 6.49 % 9.25 % 22.93 % 74.75 %
Revenue Growth - 31.26 % 7.76 % 10.17 % 24.65 % 76.23 %
Revenue 3 Year -24.54 % 90.51 % 55.67 % 59.87 % 91.84 % 241.5 %
Revenue 5 Year - 124.2 % 110.3 % 218.58 % 215.48 % 1865.57 %
Revenue 10 Year -85.61 % 66.11 % 549.62 % 608.27 % 494.04 % 1810.11 %
EBIT Growth -5.7 % 37.11 % -14.6 % -12.94 % 10.13 % 64.06 %
Net Income Growth 5.32 % 50.71 % -8.87 % 8.96 % 9.51 % 61.08 %
Net Income 3 Yeari Growth Per Share 49.36 % 106.79 % 13.48 % 34.59 % -764.83 % 52.78 %
Net Income 5 Yeari Growth Per Share -21.71 % 133.86 % 74.02 % 70.33 % -276.93 % 53.44 %
Net Income 10 Yeari Growth Per Share -2468.52 % 98.61 % 871.12 % 809.6 % -624.16 % -143.14 %
Operating Income Growth -5.7 % 37.11 % -14.6 % -12.94 % 10.13 % 64.06 %
Operating Cash Flow Growth (CFG) 7.81 % 38.06 % -8.39 % -14.35 % 9.07 % 119.24 %
Operating 3 Year CFG -19.36 % 118.29 % 76.95 % 9.63 % -148.34 % 115.59 %
Operating 5 Year CFG -477.11 % 163.51 % 125.17 % 174.78 % -195.86 % 114.91 %
Operating 10 Year CFG -273.99 % 150.92 % 713.56 % 6084.35 % -2622.09 % 174.76 %
EPS Growth 29.82 % 52.28 % -8.54 % 8.33 % 10.81 % 62.15 %
EPS Diluted Growth 29.82 % 52.37 % -9.03 % 8.35 % 10.81 % 62.15 %
Book Value Per Share -55.7 % 29 % 15.03 % 25.58 % -9.83 % -35.86 %
Share Holder 3 Year Equity Growth Per Share 106.57 % 75.22 % 137.56 % 104.06 % 33.92 % -119.99 %
Share Holder 5 Year Equity Growth Per Share 383.39 % 121.9 % 219.1 % 291.14 % 220.81 % -113.65 %
Share Holder 10 Year Equity Growth Per Share -27.26 % 49.62 % 1286.9 % 1030.79 % 691.19 % -140.22 %
Dividend Per Share Growth - 26.89 % - - - -
Dividend 3 Year Growth Per Share - 64.4 % - - - -
Dividend 5 Year Growth Per Share - 80.03 % - - - -
Dividend 10 Year Growth Per Share - 95.44 % - - - -
Debt Growth - 4.74 % 0.06 % 44.1 % -23.28 % 103.19 %
Free Cash Flow Growth 7.81 % 9.17 % -17.11 % -16.47 % 3.67 % 106.84 %
Updated On 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2022 31 Dec 2023
Profitability
SILO NVO REGN VRTX SGEN ALNY
Gross Profit Margin TTM -605.19 % 84.53 % 86.08 % 86.43 % 75.4 % 87 %
Return on Assets TTM -43.73 % 24.34 % 11.98 % -2.43 % -20.64 % -1.82 %
Return on Equity TTM -56.41 % 87.5 % 16.3 % -2.91 % -28.06 % 47.92 %
Return on Capital Employed TTM -56.88 % 61.51 % 12.08 % -2.36 % -29.5 % 3.47 %
Net Income Per EBT TTM 102.02 % 79.6 % 94.21 % -228.18 % 101.53 % 118.22 %
EBT Per Ebit TTM 90.2 % 101.17 % 116.55 % -54.74 % 93.47 % -60.11 %
EBIT Per Revenue TTM -5297.23 % 43.26 % 29.18 % -3.8 % -34.37 % 4.38 %
Cash Flow To Debt Ratio TTM 283.97 % 202.13 % 205.21 % -101.14 % -475.96 % 15.08 %
Receivables Turnover TTM - 3.88 2.36 6.23 3.64 7.58
Payables Turnover TTM 0.41 1.34 3.34 4.27 2.52 4.12
Inventory Turnover TTM - 1.1 0.65 1.53 1.07 3.63
Fixed Asset Turnover TTM - 234.59 % 313.27 % 583 % 471.71 % 327.68 %
Asset Turnover TTM 0.9 % 69.85 % 37.38 % 51.28 % 63.3 % 58.47 %
Operating Cash Flow Per Share TTM -1.16 25.87 37.65 -3.66 -2.87 2.94
Free Cash Flow Per Share TTM -1.16 14.81 29.68 -5.52 -3.73 2.52
Cash Per Share TTM 249.24 % 1405.52 % 9080.94 % 2245.45 % 657.5 % 2071.01 %
Operating Cash Flow Sales Ratio TTM -4926.11 % 44.7 % 30.18 % -9.14 % -23.48 % 15.88 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 57.25 % 78.82 % 151.04 % 129.82 % 85.66 %
Cash Flow Coverage Ratios TTM 283.97 % 202.13 % 205.21 % -101.14 % -475.96 % 15.08 %
Price To Free Cash Flows Ratio TTM -1.48 61.07 40.03 -89.77 -61.54 105.76
Price To Operating Cash Flows Ratio TTM -1.01 36.31 31.46 -135.58 -79.67 89.43
Price Cash Flow Ratio TTM -1.01 36.31 31.46 -135.58 -79.67 89.43
Income Statement (TTM)
SILO NVO REGN VRTX SGEN ALNY
Revenue $0B $232.26B $13.12B $9.84B $1.96B $1.83B
Gross Profit $-0B $196.5B $11.3B $8.58B $1.55B $1.52B
Gross Profit Ratio -1116.97% 84.6% 86.16% 87.17% 79.1% 83.02%
EBITDA $-0B $112.94B $5.13B $3.93B $-0.62B $-0.23B
Net Income $-0B $83.68B $3.95B $3.62B $-0.61B $-0.44B
EPS Diluted -1.2 18.62 34.77 13.89 -3.3 -3.52
Balance Sheet (MRQ)
SILO NVO REGN VRTX SGEN ALNY
Long Term Debt $0B $20.53B $2.7B $0.72B $0.04B $2.34B
Total Liabilities $0B $207.93B $7.11B $5.15B $0.87B $4.05B
Total Equity $0.01B $106.56B $25.97B $17.58B $2.8B $-0.22B
Total Investments $0B $17.5B $13.51B $3.45B $1.42B $1.68B
Total Debt $0B $27.01B $2.7B $0.81B $0.04B $2.68B
Total Assets $0.01B $314.49B $33.08B $22.73B $3.67B $3.83B
Cash Flow Statement (TTM)
SILO NVO REGN VRTX SGEN ALNY
Net Income $-0B $83.68B $3.95B $3.62B $-0.61B $-0.44B
Inventory $-0B $-7.42B $-0.27B $-0.32B $-0.23B $0.02B
Dividends Paid $0B $-31.77B $0B $0B $0B $0B
Operating Cash Flow $-0B $108.91B $4.59B $3.54B $-0.45B $0.1B
Capital Expenditure $0B $-38.9B $-0.93B $-0.26B $-0.08B $-0.06B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 1.81
ABCL AbCellera Biologics Inc. 2.56
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.7
ABIO ARCA biopharma, Inc. 2.4
ABOS Acumen Pharmaceuticals, Inc. 2.74
ABSI Absci Corporation 4.4
ABUS Arbutus Biopharma Corporation 3.87
ABVC ABVC BioPharma, Inc. 0.6753
ABVX Abivax SA American Depositary Shares 12.71
ACAD ACADIA Pharmaceuticals Inc. 16.58
ACER Acer Therapeutics Inc. 0.9
ACET Adicet Bio, Inc. 1.46
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 0.72
ACHV Achieve Life Sciences, Inc. 4.39
ACIU AC Immune SA 3.23
ACLX Arcellx, Inc. 68.74
ACRV Acrivon Therapeutics, Inc. Common Stock 9.49
ACST Acasti Pharma Inc. 2.62
ETFs With Exposure to SILO
Ticker ETF Name Weight Percentage Price
EIDO iShares MSCI Indonesia ETF 0.11 21.77
VXF Vanguard Extended Market Index Fund 0 179.52
EMIM.L iShares Core MSCI EM IMI UCITS ETF 0 2651
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 136.29
IEMS.L iShares MSCI EM Small Cap UCITS ETF USD (Dist) 0.02 91.815
IMIB.MI iShares FTSE MIB UCITS ETF EUR (Dist) 0 20.865
ISFE.L iShares MSCI AC Far East ex-Japan Small Cap UCITS ETF USD (Dist) 0.03 2414.25
EIMI.L iShares Public Limited Company - iShares Core MSCI EM IMI UCITS ETF 0 34.83
IS3N.DE iShares Core MSCI EM IMI UCITS ETF 0.00194 31.497
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 136.3
EUNI.DE iShares MSCI EM Small Cap UCITS ETF USD (Dist) 0.03258 83.31
IMIB.L iShares II Public Limited Company - iShares FTSE MIB UCITS ETF EUR (Dist) 0 1754.3
VEMPX Vanguard Extended Market Index InstlPlus 0 336.35
Unlock